Supportive therapies in sepsis: a closer look to the evidence

References

• Parrillo JE. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 1993; 328: 1471–1477.
   PubMed Web of Science ®Google Scholar
• Weikert LF, Bernard GR. Pharmacotherapy of sepsis. Clin. Chest Med. 1996; 17: 289–305.
   PubMed Web of Science ®Google Scholar
• Task Force of the American College of Critical Care Medi-cine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit. Care Med. 1999; 27: 639–660.
   PubMed Web of Science ®Google Scholar
• Wojnar MM, Hawkins WG, Lang CH. Nutritional support of the septic patient. Crit. Care Clin. 1995; 11: 717–733.
   Google Scholar
• Cerra FB, Benitez MR, Blackburn GL, et al. Applied nutri-tion in ICU-patients. A consensus statement of the Ameri-can College of Chest Physicians. Chest 1997; 111: 769–778.
   PubMed Web of Science ®Google Scholar
• Chiolero R, Revelly JP, Tappy L. Energy metabolism in sep-sis and injury. Nutrition 1997; 13 (9 Suppl): 45S–515.
   Google Scholar
• Ulrich H, Pastores SM, Katz DP, et al. Parenteral use of medium-chain triglycerides : A reappraisal. Nutrition 1996; 12: 231–238.
   PubMed Web of Science ®Google Scholar
• Griffiths RD, Palmer TEA, Jones C. Nutrition and survival. In: Vincent J-L (Ed), Yearbook of Intensive Care and Emer-gency Medicine. Berlin; Springer- Verlag, 1997, pp. 715–723.
   Google Scholar
• Heyland DK. Nutritional support in the critically ill patient. A critical review of the evidence. Crit. Care Clin. 1998; 14: 423–440.
   PubMed Web of Science ®Google Scholar
• Heyland DK, MacDonald S, Keefe L, et al. Total parenteral nutrition in the critically ill patient. JAMA 1998; 280: 2013–2019.
   PubMed Web of Science ®Google Scholar
• Zaloga GP, Roberts PR. Early enteral feeding improves out-come. In: Vincent J-L (Ed), Yearbook of Intensive Care and Emergency Medicine. Berlin; Springer-Verlag, 1997, pp. 701–714.
   Google Scholar
• Groos S, Hunefeld G, Luciano IT Parenteral versus enteral nutrition : Morphological changes in human adult intesti-nal mucosa. J. Submicrosc. Cytol. Pathol. 1996; 28: 61–74.
   PubMed Web of Science ®Google Scholar
• Heyland D, Winder B, Cook D, et al. Do critically ill patients tolerate early, intragastric nutrition? Clin. Int. Care 1996; 7: 68–73.
   Google Scholar
• Minard G, Kudsk ICA. Is early feeding beneficial? How early is early? New Horiz. 1994; 2: 156–163.
   Google Scholar
• Dive A, Miesse C, Galanti L, et al. Effect of erythromycine on gastric motility in mechanically ventilated patients: A double-blind, randomized, placebo-controlled study. Crit. Care Med. 1995; 23: 1356–1362.
   PubMed Web of Science ®Google Scholar
• Spapen H, Duinslaeger L, Diltoer M, et al. Gastric empty ing in critically ill patients is accelerated by adding cisapride to a standard enteral feeding protocol : Results of a prosp-ective, randomized, controlled trial. Crit. Care Med. 1995; 23: 481–485.
   PubMed Web of Science ®Google Scholar
• Chee HL, Bihari D. Enteral nutrition in the critically ill pa tient. A practical approach. In: Vincent J-L (Ed), Yearbook of Intensive Care and Emergency Medicine. Berlin; Springer-Verlag, 1998, pp. 618–626.
   Google Scholar
• Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemented arginine, RNA, and omega-3 fatty acids in patients after operation: Immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56–67.
   PubMed Web of Science ®Google Scholar
• Atkinson S, Sieffert E, Bihari D, et al. A prospective, randomized, double-blind, controlled clinical trial of en-teral immunonutrition in the critically ill. Crit. Care Med. 1998; 26: 1164–1172.
   PubMed Web of Science ®Google Scholar
• Bower RH, Cerra FB, Bershadsky B, et al. Early enteral ad-ministration of a formula (Impact) supplemented with ar-ginine, nucleotides, and fish oil in intensive care unit pa-tients: Results of a multicenter, prospective, randomized, clinical trial. Crit. Care Med. 1995; 23: 436–449.
   PubMed Web of Science ®Google Scholar
• Galban C, Celaya S, Marco P, et al. An immune-enhancing enteral diet reduces mortality and episodes of bacteremia in septic ICU patients. J. Parent. Ent. Nutr.1998; 22: S13.
   Google Scholar
• Moore F, Moore E, Kudsk K, et al. Clinical benefits of an immune-enhancing diet for early post injury enteral feed ing. J. Trauma 1994; 37: 607–615.
   PubMed Web of Science ®Google Scholar
• Kudsk K, Minard G, Croce M, et al. A randomized trial of isonitrogenous enteral diets after severe trauma : An imm-une-enhancing diet reduces septic complications. Ann. Surg. 1996; 224: 531–543.
   PubMed Web of Science ®Google Scholar
• Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the criti-cally ill: A systematic review on clinical outcome. Crit. Care Med. 1999; 27: 2799–2805.
   Web of Science ®Google Scholar
• Koretz RL. Nutritional supplementation in the ICU. How critical is nutrition for the critically ill? Am. J. Resp. Crit. Care Med. 1995; 151: 570–573.
   PubMed Web of Science ®Google Scholar
• Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dys-function syndrome. Am.J. Gastroenterol. 1996; 91: 1697–1710.
   Google Scholar
• Tryba M, Cook D. Current guidelines on stress ulcer prophy-laxis. Drugs 1997; 54: 581–596.
   PubMed Web of Science ®Google Scholar
• Cook D, Fuller H, Guyatt G, et al. Risk factors for gastro-intestinal bleeding in critically ill patients. N. Engl. J. Med. 1994; 330: 377–381.
   PubMed Web of Science ®Google Scholar
• Zandstra DF, Stoutenbeek CP. The virtual absence of stress ulceration related bleeding in ICU patients receiving pro-longed mechanical ventilation without any prophylaxis. A prospective cohort study. Int. Care Med. 1994; 20: 335–340.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophy-laxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308–314.
   PubMed Web of Science ®Google Scholar
• Cook D, Witt L, Cook R, et al. Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am. J. Med. 1991; 91: 519–527.
   PubMed Web of Science ®Google Scholar
• Tones A, El-Ebiary M, Soler N, et al. Stomach as a source of colonization of the respiratory tract during mechanical ven-tilation : Association with ventilator-associated pneumo-nia. Eur. Resp. J. 1996; 9: 1729–1735.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Laine LA, Guyatt GH, et al. Nosocomial pneumo-nia and the role of gastric pH. A meta-analysis. Chest 1991; 100: 7–13.
   Google Scholar
• Tryba M, Cook DJ. Gastric alkalinization, pneumonia, and systemic infections: The controversy. Scand. J. Gastroenterol. 1995; 30 (Suppl 210): 53–59.
   Google Scholar
• Marik PE. Stress ulcer prophylaxis: A practical approach. J. Int. Care Med. 1999; 14: 1–8.
   Web of Science ®Google Scholar
• Sirvent JM, Verdaguer R, Ferrer MJ, et al. Mechanical venti-lation-associated pneumonia and the prevention of stress ulcer. A randomized clinical trial of antacids and ranitidine versus sucralfate. Med. Clin. (Barc) 1994; 102: 407–411.
   Google Scholar
• Bonten MJ, Gaillard CA, van der Geest S, et al. The role of intragastric acidity and stress ulcer prophylaxis on coloni-zation and infection in mechanically ventilated ICU pat-ients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am. J. Resp. Crit. Care Med. 1995; 152: 1825–1834.
   Google Scholar
• Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N. Engl. J. Med. 1998; 338: 791–797.
   Google Scholar
• Trofe J, Peterson AM. The role of H2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients. Pharmacotherapy 1998; 18: 808–815.
   PubMed Web of Science ®Google Scholar
• Fink MP, Nelson R, Roethel R. Low-dose dopamine pre-serves renal blood flow in endotoxin shocked dogs treated with ibuprofen. J. Surg. Res. 1985; 38: 582–591.
   Google Scholar
• Strigle TR, Petrinec D. The effect of renal range dopamine and norepinephrine infusions on the renal vasculature. Am. Surg. 1990; 56: 494–496.
   PubMed Web of Science ®Google Scholar
• Bersten AD, Rutten AJ. Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis. Crit. Care Med. 1995; 23: 537–544.
   PubMed Web of Science ®Google Scholar
• Schmidt H, Secchi A, Wellmann R, et al. Effect of low-dose dopamine on intestinal villus microcirculation during nor-motensive endotoxaemia in rats. Br. J. Anaesth. 1996; 76: 707–712.
   PubMed Web of Science ®Google Scholar
• McDonald RH, Goldberg LI, McNay JL, et al. Effects of dopamine in man : Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J. Clin. Invest. 1964; 43: 1116–1124.
   PubMed Web of Science ®Google Scholar
• Goldberg LI, McDonald RH, Zimmerman AM. Sodium diu-resis produced by dopamine in patients with congestive heart failure. N. Engl. J. Med. 1963; 269: 1060–1064.
   Google Scholar
• Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit. Care. Med. 1994; 22: 61–66.
   Google Scholar
• Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine? Crit. Care Med. 1994; 22: 1919–1925.
   Google Scholar
• Baldwin L, Henderson A, Hickman P. Effect of postopera-tive low-dose dopamine on renal function after elective ma-jor vascular surgery. Ann. Intern. Med. 1994; 120: 744–749.
   Google Scholar
• Myles PS, Buckland MR, Schenk NJ, et al. Effect of "renal-dose" dopamine on renal function following cardiac surg-ery. Anaesth. Int. Care 1993; 21: 56–61.
   PubMed Web of Science ®Google Scholar
• Richer M, Robert S, Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit. Care Med. 1996; 24: 1150–1154
   Google Scholar
• Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit. Care Med. 1998; 26: 260–265.
   Google Scholar
• Girbes ARJ, Patten MT, McCloskey By, et al. The renal and neurohumeral effects of the addition of low-dose dopamine in septic critically-ill patients. Int. Care Med. 1996; 22 (Suppl 3): S391.
   Google Scholar
• Olson D, Pohlman A, Hall JB. Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creati-nine clearance. Am. J. Resp. Crit. Care Med. 1996; 154: 1664–1670.
   Google Scholar
• Lherm T, Troche G, Rossignol M, et al. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Int. Care Med. 1996; 22: 213–219.
   PubMed Web of Science ®Google Scholar
• Juste RN, Panikkar K, Soni N. The effects of low-dose dopamine infusions on haemodynamic and renal param-eters in patients with septic shock requiring treatment with noradrenaline. Int. Care Med. 1998; 24: 564–568.
   Google Scholar
• Juste RN, Moran L, Hooper J, et al. Dopamine clearance in critically ill patients. Int. Care Med. 1998; 24: 1217–1220.
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit. Care Med. 1996; 24: 1580–1590.
   PubMed Web of Science ®Google Scholar
• Kadieva VS, Friedman L, Margolius LP, et al. The effect of dopamine on graft functions in patients undergoing renal transplantation. Anesth. Analg. 1993; 76: 362–365.
   PubMed Web of Science ®Google Scholar
• Jain M, Schmidt GA. Venous thromboembolism: Preven-tion and prophylaxis. Sem. Resp. Crit. Care Med. 1997; 18: 79–90.
   Web of Science ®Google Scholar
• Anderson FA, Wheeler HB. Venous thromboembolism. Risk factors and prophylaxis. Clin. Chest Med. 1995; 16: 235–251.
   PubMed Web of Science ®Google Scholar
• Belch JJ, Lowe GD, Ward AG, et al. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med. J. 1981; 26: 115–117.
   PubMed Web of Science ®Google Scholar
• Cade JF. High risk of the critically ill for venous thrombo-embolism. Crit. Care Med. 1982; 10: 448–450.
   PubMedGoogle Scholar
• Halldn H, Goldberg J, Modan M, et al. Reduction of mortal ity in general medical in- patients by low-dose heparin prophylaxis. Ann. Intern. Med. 1982; 96: 561–565.
   PubMed Web of Science ®Google Scholar
• Pingleton SK, Bone RC, Pingleton WW, et al. Prevention of pulmonary emboli in a respiratory intensive care unit: Effi-ciency of low-dose heparin. Chest 1981; 79: 647–650.
   PubMed Web of Science ®Google Scholar
• Dahan R, Houlbert D, Caulin C, et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low mol-ecular weight heparin : A randomized double-blind trial. Haemostasis 1986; 16: 159–164.
   PubMedGoogle Scholar
• Harenberg J, Kallenbach B, Martin U, et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb. Res. 1990; 59: 639–650.
   PubMed Web of Science ®Google Scholar
• Tapson VF, Hull RD. Management of venous thromboem-bolic disease. The impact of low-molecular-weight heparin. Clin. Chest Med. 1995; 16: 281–294.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Parkin G, Love J, et al. Use of continuous hemodiafiltration : An approach to the management of acute renal failure in the critically ill. Am. J. Nephrol. 1992; 12: 240–245.
   PubMed Web of Science ®Google Scholar
• Kierdorf H, Sieberth HG. Continuous treatment modalities in acute renal failure.Nephro/. Dial. Transplant 1995; 10: 2001-2008.
   Google Scholar
• Bellomo R. Continuous hemofiltration as blood purifica-tion in sepsis. New Horiz. 1995; 3: 732–737.
   PubMedGoogle Scholar
• Silvester W. Mediator removal with CRRT : Complement and cytokines. Am. J. Kidney Dis. 1997; 30 (Suppl 4): 538–543.
   Google Scholar
• Schetz M, Ferdinande P, Van Den Berghe G, et al. Removal of pro-inflammatory cytokines with renal replacement therapy : Sense or nonsense ? Int. Care Med. 1995; 21: 169–176.
   Google Scholar
• Kellum JA, Johnson JP, Kramer D, et al. Diffuse vs. convec-tive therapy: Effects on mediators of inflammation in pat-ients with severe inflammatory response syndrome. Crit. Care Med. 1998; 26: 1995–2000.
   Google Scholar
• De Vriese AS, Colardyn FA, Lameire NH. Continuous renal replacement therapies in sepsis. Do they matter? In: Vin-cent J-L (Ed), Yearbook of Intensive Care and Emergency Medicine. Berlin; Springer-Verlag, 1999, 611–620.
   Google Scholar
• Cosentino F, Paganini E, Lockrem J, et al. Continuous arterio-venous hemofiltration in the adult respiratory distress syndrome. Contrib. Nephrol. 1991; 93: 94–97.
   PubMedGoogle Scholar
• Manasia A, Ezeugwu C, Geffroy V, et al. The role of con-tinuous veno-venous hemofiltration in the management of acute respiratory distress syndrome - A randomized prospective trial. Blood Purif. 1995; 13: 393.
   Google Scholar
• Davenport A, Will EJ, Davidson AM. Improved cardiovas-cular stability during continuous modes of renal replace-ment therapy in critically ill patients with acute hepatic and renal failure. Crit. Care Med. 1993; 21: 328–338.
   Google Scholar
• John S, Griesbach D, Baumgärtel M, et al. CVVH does not improve splanchnic mircocirculation in septic shock com pared to hemodialysis. Int. Care Med. 1998; 24 (Suppl 1): S75.
   Google Scholar
• Sander A, Armbruster W, Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory res-ponse syndrome but does not alter IL-6 and TNF-a plasma concentrations. Int. Care Med. 1997; 23: 878–884.
   PubMed Web of Science ®Google Scholar
• Jakob SM, Frey FJ, Vehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of patients? Nephrol. Dial. Transplant 1996; 11: 1250–1255.
   Google Scholar
• Bellomo R, Baldwin I, Cole L, et al. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int. 1998; 53: S182–S185.
   Web of Science ®Google Scholar